AstraZeneca Non-Clinical PhD Studentship in Next-generation TPD for oncology: Harnessing ubiquitin-independent pathways
Not stated
- Location
- Cambridge, United Kingdom
- Funding
- See university guidance
- Application deadline
About the project
- Study at Cambridge
- About the University
- Research at Cambridge
- For Cambridge students
- For staff
- For alumni
- For our researchers
- Business and enterprise
- Colleges and Departments
- Give to Cambridge
- Libraries
- Museums and collections
- Study at Cambridge
- Undergraduate Undergraduate courses Applying Events and open days Fees and finance
- Undergraduate courses
- Applying
- Events and open days
- Fees and finance
- Postgraduate Postgraduate courses How to apply Postgraduate events Fees and funding
- Postgraduate courses
- How to apply
- Postgraduate events
- Fees and funding
- International students
- Continuing education
- Lifelong learning
- Courses in education
- About the University
- How the University and Colleges work
- Term dates and calendars
- History
- Map
- Visiting the University
- News
- Annual reports
- A global university
- Equality and diversity
- Events
- Public engagement
- Jobs
- Give to Cambridge
- Research at Cambridge
- For Cambridge students
- For staff
- For alumni
- For our researchers
- Business and enterprise
- Colleges and Departments
- Give to Cambridge
- Libraries
- Museums and collections
AstraZeneca Non-Clinical PhD Studentship in Next-generation TPD for oncology: Harnessing ubiquitin-independent pathways
The Department of Pharmacology at the University of Cambridge, in partnership with AstraZeneca, is offering a funded PhD studentship to study proteasome-targeting tools and use them to design novel approaches for Targeted Protein Degradation (TPD). We are seeking a motivated and curiosity-driven student with a strong interest in cell biology and biochemistry, as well as an enthusiasm for TPD approaches.
The successful candidate will join the lab of Dr Catherine Lindon in the Department of Pharmacology, with a supervisory team that includes Dr Gustavo Gutierrez (Discovery Sciences, AstraZeneca), Professor Laura Itzhaki (Department of Pharmacology), Dr Sharan Bagal (Oncology Chemistry, AstraZeneca) and Dr David McGarry (Oncology Bioscience, AstraZeneca).
Project Aims:
The project aims to establish a novel TPD platform by co-opting Midnolin, a protein capable of delivering substrates directly to the proteasome, for ubiquitin-independent degradation. The research programme will include an exploration of Midnolin biology, to understand its endogenous regulation across cellular time and space, and the development of novel tools to direct Midnolin activity towards desirable targets linked to therapeutic outcomes. This part of the project will include a campaign to discover binders that can harness the cell's endogenous Midnolin pool, and engineering of custom exogenous Midnolin-based degrader tools, for directed degradation of oncology targets.
We are seeking a highly motivated individual able to work independently, and with good knowledge and/or experience in both biochemistry and cell biology. Applicants should have or shortly expect to obtain a first or high 2:1 bachelor's degree from a UK university, or an equivalent standard from an overseas university, in a relevant subject.
Funding
The funding for this post is available for 4 years. Funding will cover the student's stipend and tuition fees at the Home rate. This studentship is also open to overseas students who meet the UK residency requirements (home fees) or who can cover the extra costs associated with international student fees through scholarships or funding schemes. Students may not supplement fees via self-funding.
How to Apply
The deadline for applications is Tuesday 8th December 2026. Applications should be made via the University Application portal. When asked to select a course, please apply for the PhD in Pharmacology. You should then put the title of this studentship as your proposed project title.
You are not required to write your own research proposal. When asked for a research proposal in the applicant portal, instead please upload one side of A4 with your motivation for applying for the studentship, your relevant skills, what you hope to achieve if appointed, and long-term career aspirations.
Informal enquiries about the project are welcome and should be directed to Dr Catherine Lindon: acl34@cam.ac.uk
For application process queries, please contact the Postgraduate Admissions Team https://www.postgraduate.study.cam.ac.uk/contact-us
Please quote reference PL51373 on your application and in any correspondence about this vacancy.
The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
Department/location
Department of Pharmacology
Reference
PL51373
Category
Studentships
Date published
12 October 2026
Closing date
16 November 2026
Connect with us
© 2026 University of Cambridge
- X
- YouTube
- Contact the University
- Accessibility
- Freedom of information
- Privacy policy and cookies
- Statement on Modern Slavery
- Terms and conditions
- University A-Z
Study at Cambridge
- Undergraduate
- Postgraduate
- Lifelong learning
- Courses in education
About the University
- How the University and Colleges work
- Give to Cambridge
- Jobs
- Map
- Visiting the University
- Cambridge University Press & Assessment
Research at Cambridge
- Research news
- About research at Cambridge
- Public engagement